224 related articles for article (PubMed ID: 21945430)
1. Treatment outcomes between concurrent chemoradiotherapy and combination of surgery, radiotherapy, and/or chemotherapy in stage III and IV maxillary sinus cancer: multi-institutional retrospective analysis.
Kang JH; Cho SH; Kim JP; Kang KM; Cho KS; Kim W; Seol YM; Lee S; Park HS; Hur WJ; Choi YJ; Oh SY
J Oral Maxillofac Surg; 2012 Jul; 70(7):1717-23. PubMed ID: 21945430
[TBL] [Abstract][Full Text] [Related]
2. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
3. The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma.
Malaisrie SC; Hofstetter WL; Correa AM; Ajani JA; Komaki RR; Rice DC; Vaporciyan AA; Walsh GL; Roth JA; Wu TT; Swisher SG
Cancer; 2006 Sep; 107(5):967-74. PubMed ID: 16874819
[TBL] [Abstract][Full Text] [Related]
4. Outcomes and toxicities for the treatment of stage IVB cervical cancer.
Hwang JH; Lim MC; Seo SS; Kang S; Park SY; Kim JY
Arch Gynecol Obstet; 2012 Jun; 285(6):1685-93. PubMed ID: 22173823
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of advanced maxillary sinus squamous carcinoma: an analysis of 92 cases].
Su YR; Wu GH; Zeng ZY; Guo ZM; Chen WK; Wei MW; Chen YF
Ai Zheng; 2008 May; 27(5):535-8. PubMed ID: 18479606
[TBL] [Abstract][Full Text] [Related]
6. Maxillary sinus carcinoma. Natural history and outcome.
Al-Jhani AS; Al-Rajhi NM; El-Sebaie MM; Nooh NS; Mahasen ZZ; Al-Amro AS; Otieschan AT
Saudi Med J; 2004 Jul; 25(7):929-33. PubMed ID: 15235702
[TBL] [Abstract][Full Text] [Related]
7. Combined-modality treatment for advanced oral tongue squamous cell carcinoma.
Fan KH; Lin CY; Kang CJ; Huang SF; Wang HM; Chen EY; Chen IH; Liao CT; Cheng AJ; Chang JT
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):453-61. PubMed ID: 17236967
[TBL] [Abstract][Full Text] [Related]
8. Can concurrent chemoradiotherapy replace surgery and postoperative radiation for locally advanced stage III/IV tonsillar squamous cell carcinoma?
Park G; Lee SW; Kim SY; Nam SY; Choi SH; Kim SB; Roh JL; Yoon DH; Kim SS; Park JH; Kim YS; Yoon SM; Song SY; Kim JH; Choi EK; DO Ahn S
Anticancer Res; 2013 Mar; 33(3):1237-43. PubMed ID: 23482808
[TBL] [Abstract][Full Text] [Related]
9. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and safety of concurrent chemoradiotherapy for maxillary sinus squamous cell carcinoma patients.
Nishimura G; Tsukuda M; Mikami Y; Matsuda H; Horiuchi C; Satake K; Taguchi T; Takahashi M; Kawakami M; Hanamura H; Watanabe M; Utsumi A
Auris Nasus Larynx; 2009 Oct; 36(5):547-54. PubMed ID: 19097833
[TBL] [Abstract][Full Text] [Related]
11. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.
Chen QY; Wen YF; Guo L; Liu H; Huang PY; Mo HY; Li NW; Xiang YQ; Luo DH; Qiu F; Sun R; Deng MQ; Chen MY; Hua YJ; Guo X; Cao KJ; Hong MH; Qian CN; Mai HQ
J Natl Cancer Inst; 2011 Dec; 103(23):1761-70. PubMed ID: 22056739
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: experience at a single institution.
Malaisrie SC; Untch B; Aranha GV; Mohideen N; Hantel A; Pickleman J
Arch Surg; 2004 May; 139(5):532-8; discussion 538-9. PubMed ID: 15136354
[TBL] [Abstract][Full Text] [Related]
13. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic analysis of 151 patients with maxillary sinus malignant neoplasms].
Guo GF; Yang AK; Xie RH; Chen ZH; Wu QL; Ou SM; Liu WW; Xia LP; Chen MY; Zhang JX; Wu JH
Ai Zheng; 2004 Nov; 23(11 Suppl):1546-50. PubMed ID: 15566677
[TBL] [Abstract][Full Text] [Related]
15. Preoperative chemotherapy and radiation therapy for squamous cell carcinoma of the maxillary sinus.
Isobe K; Uno T; Hanazawa T; Kawakami H; Yamamoto S; Suzuki H; Iida Y; Ueno N; Okamoto Y; Ito H
Jpn J Clin Oncol; 2005 Nov; 35(11):633-8. PubMed ID: 16275677
[TBL] [Abstract][Full Text] [Related]
16. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG
Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma.
Hsu FM; Lee JM; Huang PM; Lin CC; Hsu CH; Tsai YC; Lee YC; Chia-Hsien Cheng J
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e593-9. PubMed ID: 21658851
[TBL] [Abstract][Full Text] [Related]
18. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
[TBL] [Abstract][Full Text] [Related]
19. Salvage operations for patients with persistent or recurrent cancer of the maxillary sinus after superselective intra-arterial infusion of cisplatin with concurrent radiotherapy.
Sakashita T; Homma A; Hatakeyama H; Kano S; Mizumachi T; Furusawa J; Yoshida D; Fujima N; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Suzuki F; Fukuda S
Br J Oral Maxillofac Surg; 2014 Apr; 52(4):323-8. PubMed ID: 24582012
[TBL] [Abstract][Full Text] [Related]
20. Another way to estimate outcome of advanced nasopharyngeal carcinoma--is concurrent chemoradiotherapy adequate?
Lin JC; Liang WM; Jan JS; Jiang RS; Lin AC
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):156-64. PubMed ID: 15337551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]